Frontotemporal Dementia clinical trials
The registry lists 208 studies for Frontotemporal Dementia across more than 10 countries. 72 are recruiting or about to start. 71 of them are mainly about Frontotemporal Dementia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Frontotemporal Dementia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Mayo Clinic (7) · University of California, San Francisco (6) · National Institute of Neurological Disorders and Stroke (NINDS) (6) · Assistance Publique - Hôpitaux de Paris (6) · University of Pennsylvania (5) · Chang Gung Memorial Hospital (5) · Massachusetts General Hospital (4) · Johns Hopkins University (4)
What is being tested here
Drugs under test in Frontotemporal Dementia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Nov 2026[18F]ACI-19626 PET in TDP-43 Proteinopathies · AC Immune SA
- Nov 2026Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling · University Health Network, Toronto
- Dec 2026A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN) · Denali Therapeutics Inc.
- Dec 2026Transcranial Alternating Current Stimulation in Frontotemporal Dementia · IRCCS Centro San Giovanni di Dio Fatebenefratelli
- Dec 2026Diagnosing Frontotemporal Lobar Degeneration · University Health Network, Toronto
- Dec 2026The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia · Samsung Medical Center
- Dec 2026Retinal Imaging in Neurodegenerative Disease · Duke University
- Dec 2026Memory and Social Interactions · University Hospital, Caen
- Jan 2027DC Longitudinal Study on Aging and Specimen Bank · Georgetown University
- Jan 2027Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology · Peter Ljubenkov, MD
Who these studies take
Of the 51 Frontotemporal Dementia studies recruiting now, 29 (57%) set no upper age limit and 5 (10%) stop at 75 or younger. 6 (12%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 30 (59%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 6 (12%) | 6 (12%) |
| 18 | 23 (45%) | 23 (45%) |
| 30 | 30 (59%) | 30 (59%) |
| 40 | 41 (80%) | 41 (80%) |
| 50 | 49 (96%) | 49 (96%) |
| 65 | 50 (98%) | 50 (98%) |
| 75 | 48 (94%) | 48 (94%) |
| 85 | 45 (88%) | 45 (88%) |
Across all 208 studies, recruiting or not: 7% stop at 75 or younger and 1% at 65; 12% take children; <1% are for women only and <1% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Frontotemporal Dementia studies take
Of 19 phase 2 interventional studies under Frontotemporal Dementia, half reached primary completion within 55 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 2 | 55 mo42–64 · 19 studies | — | — |
| Interventional, no phase | 41 mo21–97 · 54 studies | — | 41 mo21–97 · 51 studies |
| Observational | 88 mo44–… · 46 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Stopped1
- A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesTerminatedOct 29, 2026NCT04747431
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 208. Browse all 208 → or search them.
- Trial of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease or Primary TauopathiesRecruitingNCT07221344Phase 1/22 countries
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaRecruitingNCT032251441 country
- The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1Enrolling by invitationNCT07217665Phase 21 country
- The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31Enrolling by invitationNCT07264283Phase 21 country
- Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence ModelsRecruitingNCT07906769Not applicable1 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931681 country
- Speech and Language Interventions for Italian People With PPARecruitingNCT067399671 country
- A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumNot yet recruitingNCT075693671 country
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)RecruitingNCT043636842 countries
- Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative DiseasesRecruitingNCT05326750Not applicable1 country
- Transcranial Alternating Current Stimulation in Frontotemporal DementiaRecruitingNCT07505784Not applicable1 country
- Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)Not yet recruitingNCT072007391 country
- [18F]ACI-19626 PET in TDP-43 ProteinopathiesRecruitingNCT06891716Early Phase 11 country
- AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)RecruitingNCT07158905Phase 11 country
- Using the EHR to Advance Genomic Medicine Across a Diverse Health SystemRecruitingNCT06377033Not applicable1 country
- A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)RecruitingNCT06064890Phase 1/29 countries
- MSC-Exosome Therapy for Frontotemporal DementiaNot yet recruitingNCT07638813Phase 1/2
- Neurologic Stem Cell Treatment StudyRecruitingNCT02795052Not applicable2 countries
- Imaging of Brain Amyloid Plaques in the Aging PopulationEnrolling by invitationNCT00950430Phase 41 country
- Temporal Interference Stimulation Treatment in Patients With Cognitive ImpairmentRecruitingNCT07643363Not applicable1 country
- Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive AphasiaRecruitingNCT05741853Not applicable2 countries
- Communication Bridge 3 StudyRecruitingNCT06191198Phase 21 country
- GENetic Fronto Temporal Dementia Initiative in LilleRecruitingNCT04639622Not applicable1 country
- Tanycytes in Alzheimer's Disease and Frontotemporal DementiaRecruitingNCT052888421 country
- Social & Affective Cognition in Alzheimer's Disease & Associated DisordersRecruitingNCT06338397Not applicable1 country
- Digital Measurements of Motor and Voice Functions in FTDNot yet recruitingNCT07333898
- Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental DisordersEnrolling by invitationNCT072398431 country
- Long Term Effect of Brain Stimulation in PPARecruitingNCT07158216Not applicable1 country
- Retinal Hyperspectral Imaging in Neurodegenerative DiseasesRecruitingNCT07545473Not applicable1 country
- Intervention for Communication Quality of Life in Primary Progressive AphasiaRecruitingNCT07219680Not applicable1 country
- The Swedish BioFINDER 2 StudyRecruitingNCT03174938Not applicable1 country
- Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal DementiaRecruitingNCT06604520Phase 21 country
- Language in Primary Progressive AphasiaRecruitingNCT005370041 country
- Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental DisorderEnrolling by invitationNCT073141901 country
- Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM DeviceEnrolling by invitationNCT07222605Not applicable1 country
- Retinal Imaging in Neurodegenerative DiseaseRecruitingNCT032336461 country
- Comprehensive Assessment of Neurodegeneration and DementiaRecruitingNCT034029191 country
- Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersEnrolling by invitationNCT046801301 country
- Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative ModelingRecruitingNCT065297441 country
- STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care PartnersRecruitingNCT06613204Not applicable1 country
- Speech-Language Treatment With Remotely Supervised Transcranial Direct Current Stimulation in Primary Progressive AphasiaEnrolling by invitationNCT05901233Not applicable1 country
- Primary Progressive Aphasia Multicomponent Language Treatment StudyEnrolling by invitationNCT06649084Not applicable1 country
- Investigator Initiated Study for the Safety and Efficacy in Frontotemporal DementiaNot yet recruitingNCT07154485Phase 2
- Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)RecruitingNCT013534301 country
- Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia PatientsNot yet recruitingNCT06978946Not applicable1 country
- First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in DementiaRecruitingNCT05374278Phase 1/21 country
- Genetic Frontotemporal Dementia Initiative for NeurodevelopmentRecruitingNCT057798131 country
- Diagnosing Frontotemporal Lobar DegenerationRecruitingNCT029646371 country
- Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative DisordersRecruitingNCT068037841 country
- Molecular Neuroimaging of Neuroinflammation in Neurodegenerative DementiasRecruitingNCT02945774Not applicable1 country